Ligand-exchange reactions involving octahedral W6S8 clusters and a family of pyridine-based ligands (isonicotinic acid, isonicotinamide, 4-hydroxypyridine, 4-aminopyridine, 4-pyridineacetamide) have been explored with the goal of preparing compounds that crystallize in hydrogen-bonded arrays. Two new compounds, W6S8(4-pyridineacetamide)6.DMF.4-pyridineacetamide (1) and W6S8(4-aminopyridine)6.4DMF (2), were isolated and characterized by single-crystal X-ray diffraction. Both compounds crystallize in the P2(1)/c space group with a = 16.461(1), b = 33.08(2), c = 13.165(10) A, beta = 103.270(15) degrees for 1 and a = 13.8988(5), b = 13.2791(5), c = 15.6293(6) A, beta = 108.5410(10) degrees for 2. Each compound was further characterized by 1H NMR spectroscopy, elemental (CHN) analysis, and thermogravimetric analysis. Examination of the structures shows that 1 forms a three-dimensional hydrogen-bonded network in which each 4-pyridineacetamide ligand interacts with ligands on neighboring clusters or with the free ligand of crystallization. This is the first hydrogen-bonded network formed from W6S8 clusters. In 2, the amino groups act as hydrogen-bond donors toward DMF molecules of crystallization, but an extended array is not formed. In addition, the binding strengths of these pyridine-based ligands to the W6S8 cluster were studied through quantitative 1H NMR studies of ligand-exchange reactions. A qualitative relationship was found between ligand binding strengths and Hammett substituent constants for this group of ligands.
No takes yet. Share an insight, caveat, or question.
Oertel et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: